Advertisement

Developmental Perspectives and Risk Factors for Substance Use

  • Sharon LevyEmail author
  • Miriam A. Schizer
  • Leslie S. Green
Chapter

Abstract

This chapter discusses normative adolescent development, including neurobiological and psychosocial maturation that contribute to significant vulnerabilities to substance use initiation and escalation. As brain structures mature at different rates, there is an imbalance between motivation to seek reward that drives behavior and executive functioning that filters it. Adolescence also marks the transition of the primary social group from family to peers, which may motivate adolescent substance use. The impact of individual substances on the developing brain is highlighted in the context of societal changes in risk perception and availability. Risk and protective factors that determine substance use disorder progression are discussed. Practical considerations for addressing substance use as part of routine care for children and adolescents are included.

Keywords

Brain development Social development Neurobiology Risk/protective factors Screening Health messages 

References

  1. 1.
    Arain M, Haque M, Johal L, Mathur P, Nel W, Rais A, et al. Maturation of the adolescent brain. Neuropsychiatr Dis Treat. 2013;9:449–61.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Galvan A. Adolescent development of the reward system. Front Hum Neurosci. 2010;4:6.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Lipari R, Kroutil LA, Pemberton MR. Risk and protective factors and initiation of substance use: results from the 2014 national survey on drug use and health. NSDUH Data Review; 2015. https://www.samhsa.gov/data/sites/default/files/NSDUH-DR-FRR4-2014rev/NSDUH-DR-FRR4-2014.pdf. Accessed 25 July 2018.
  4. 4.
    Gogtay N, Thompson PM. Mapping gray matter development: implications for typical development and vulnerability to psychopathology. Brain Cogn. 2010;72(1):6–15.CrossRefGoogle Scholar
  5. 5.
    Hingson RW, Heeren T, Winter MR. Age at drinking onset and alcohol dependence: age at onset, duration, and severity. Arch Pediatr Adolesc Med. 2006;160(7):739–46.CrossRefGoogle Scholar
  6. 6.
    Le Strat Y, Dubertret C, Le Foll B. Impact of age at onset of cannabis use on cannabis dependence and driving under the influence in the United States. Accid Anal Prev. 2015;76:1–5.CrossRefGoogle Scholar
  7. 7.
    McCabe SE, West BT, Morales M, Cranford JA, Boyd CJ. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction. 2007;102(12):1920–30.CrossRefGoogle Scholar
  8. 8.
    Jordan CJ, Andersen SL. Sensitive periods of substance abuse: early risk for the transition to dependence. Dev Cogn Neurosci. 2017;25:29–44.CrossRefGoogle Scholar
  9. 9.
    Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2003–2013. State Admissions to Substance Abuse Treatment Services. BHSIS Series S-80, HHS Publication No. (SMA) 16-4964. Substance Abuse and Mental Health Services Administration: Rockville; 2015.Google Scholar
  10. 10.
    Berger KS. The developing person through childhood and adolescence. 6th ed. New York: Worth Publishing; 2003.Google Scholar
  11. 11.
    Ennett ST, Bauman KE, Hussong A, Faris R, Foshee VA, Cai L, et al. The peer context of adolescent substance use: findings from social network analysis. J Res Adolesc. 2006;16(2):159–86.CrossRefGoogle Scholar
  12. 12.
    Committee on Communications, American Academy of Pediatrics C on C, Strasburger VC, Sherwood N, Story M, Walsh D, Hogan M. Children, adolescents, and advertising. Pediatrics. 2006;118(6):2563–9.CrossRefGoogle Scholar
  13. 13.
    White AM, Scott Swartzwelder H. Age-related effects of alcohol on memory and memory-related brain function in adolescents and adults. In: Galanter M, Lowman C, Boyd GM, Faden VB, Witt E, Lagressa D, editors. Recent developments in alcoholism. Boston: Springer; 2005.Google Scholar
  14. 14.
    Little PJ, Kuhn CM, Wilson WA, Swartzwelder HS. Differential effects of ethanol in adolescent and adult rats. Alcohol Clin Exp Res. 1996;20(8):1346–51.CrossRefGoogle Scholar
  15. 15.
    He J, Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav. 2007;86(2):189–99.CrossRefGoogle Scholar
  16. 16.
    National Institute on Alcohol Abuse and Alcoholism. Underage drinking. https://pubs.niaaa.nih.gov/publications/underagedrinking/Underage_Fact.pdf. Accessed 25 July 2018.
  17. 17.
    Valenzuela CF. Alcohol and neurotransmitter interactions. Alcohol Health Res World. 1997;21(2):144–8.PubMedGoogle Scholar
  18. 18.
    Mattick RP, Clare PJ, Aiken A, Wadolowski M, Hutchinson D, Najman J, et al. Association of parental supply of alcohol with adolescent drinking, alcohol-related harms, and alcohol use disorder symptoms: a prospective cohort study. Lancet Public Health. 2018;3(2):e64–71.CrossRefGoogle Scholar
  19. 19.
    Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327–60.CrossRefGoogle Scholar
  20. 20.
    Lubman DI, Cheetham A, Yücel M. Cannabis and adolescent brain development. Pharmacol Ther. 2015;148:1–16.CrossRefGoogle Scholar
  21. 21.
    Jacobus J, Tapert SF. Effects of cannabis on the adolescent brain. Curr Pharm Des. 2014;20(13):2186–93.CrossRefGoogle Scholar
  22. 22.
    Price JS, McQueeny T, Shollenbarger S, Browning EL, Wieser J, Lisdahl KM. Effects of marijuana use on prefrontal and parietal volumes and cognition in emerging adults. Psychopharmacology. 2015;232(16):2939–50.CrossRefGoogle Scholar
  23. 23.
    Schweinsburg AD, Brown SA, Tapert SF. The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev. 2008;1(1):99–111.CrossRefGoogle Scholar
  24. 24.
    Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RSE, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012;109(40):E2657–64.CrossRefGoogle Scholar
  25. 25.
    Fiellin LE, Tetrault JM, Becker WC, Fiellin DA, Hoff RA. Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults. J Adolesc Health. 2013;52(2):158–63.CrossRefGoogle Scholar
  26. 26.
    Scavone JL, Sterling RC, Van Bockstaele EJ. Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal. Neuroscience. 2013;248:637–54.CrossRefGoogle Scholar
  27. 27.
    Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE. Monitoring the future national survey results on drug use, 1975–2015: overview, key findings on adolescent drug use. Ann Arbor; 2016. http://www.monitoringthefuture.org/pubs/monographs/mtf-overview2015.pdf. Accessed 25 July 2018.
  28. 28.
    Hammond D, Reid JL, Cole AG, Leatherdale ST. Electronic cigarette use and smoking initiation among youth: a longitudinal cohort study. CMAJ. 2017;189(43):E1328–36.CrossRefGoogle Scholar
  29. 29.
    Swendsen JD, Merikangas KR. The comorbidity of depression and substance use disorders. Clin Psychol Rev. 2000;20(2):173–89.CrossRefGoogle Scholar
  30. 30.
    Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Aguilar-Gaziola S, et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the international consortium in psychiatric epidemiology. Addict Behav. 1998;23(6):893–907.CrossRefGoogle Scholar
  31. 31.
    Meyers JL, Dick DM. Genetic and environmental risk factors for adolescent-onset substance use disorders. Child Adolesc Psychiatr Clin N Am. 2010;19(3):465–77.CrossRefGoogle Scholar
  32. 32.
    Steinberg L, Fletcher A, Darling N. Parental monitoring and peer influences on adolescent substance use. Pediatrics. 1994;93(6 Pt 2):1060–4.PubMedGoogle Scholar
  33. 33.
    Bryant AL, Schulenberg JE, O’Malley PM, Bachman JG, Johnston LD. How academic achievement, attitudes, and behaviors relate to the course of substance use during adolescence: a 6-year, multiwave national longitudinal study. J Res Adolesc. 2003;13(3):361–97.CrossRefGoogle Scholar
  34. 34.
    Griffin KW, Botvin GJ. Evidence-based interventions for preventing substance use disorders in adolescents. Child Adolesc Psychiatr Clin N Am. 2010;19(3):505–26.CrossRefGoogle Scholar
  35. 35.
    Jackson C, Dickinson D. Can parents who smoke socialise their children against smoking? Results from the smoke-free kids intervention trial. Tob Control. 2003;12(1):52–9.CrossRefGoogle Scholar
  36. 36.
    Levy SJL, Williams JF. Committee on substance use and prevention. Substance use screening, brief intervention, and referral to treatment. Pediatrics. 2016;138(1):e20161211.CrossRefGoogle Scholar
  37. 37.
  38. 38.
    Levy S, Campbell MD, Shea CL, DuPont R. Trends in abstaining from substance use in adolescents: 1975–2014. Pediatrics. 2018:e20173498. https://doi.org/10.1542/PEDS.2017-3498. CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Sharon Levy
    • 1
    • 2
    Email author
  • Miriam A. Schizer
    • 1
    • 2
  • Leslie S. Green
    • 1
    • 3
  1. 1.Adolescent Substance Use and Addiction Program, Division of Developmental MedicineBoston Children’s HospitalBostonUSA
  2. 2.Department of PediatricsHarvard Medical SchoolBostonUSA
  3. 3.Department of Social WorkBoston Children’s HospitalBostonUSA

Personalised recommendations